Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses

Area of Science:

• Oncolytic virotherapy
• Gene therapy
• Adenovirus engineering

Background:

• Oncolytic adenoviruses (OAds) demonstrate limited efficacy as standalone antitumor therapies.
• Arming OAds by inserting transgenes enhances their potency for cancer treatment.

Purpose of the Study:

• To review critical parameters influencing the efficacy of armed oncolytic adenoviruses.
• To provide insights into optimizing armed OAd design for improved therapeutic outcomes.

Main Methods:

• Review of existing literature on recombinant adenoviruses for gene therapy and vaccination.
• Analysis of transgene insertion sites (E1, E3) and modifications in armed OAds.
• Evaluation of factors affecting transgene expression and virus fitness.

Main Results:

• Transgene insertion sites, including E1 and E3 regions (with deletions), are key in armed OAd design.
• Transgene location, orientation, transcriptional control, and codon usage significantly impact therapeutic potential.
• Both virocentric (virus-centric) and immunocentric (immune-centric) transgene functions are critical.

Conclusions:

• Optimizing armed OAd design requires careful consideration of multiple genetic and functional parameters.
• Strategic engineering of armed OAds holds promise for enhancing cancer immunotherapy.
• Further research into these parameters will advance the clinical application of oncolytic adenoviruses.